Allergy season is here and that likely means lots of sniffling, sneezing and coughing. Doctors weigh in on how you can best ...

Millions battle persistent skin flare-ups, facing daily discomfort and frustration. Discover the latest insights into treatment and prevention.

Incyte (Nasdaq: INCY) today announced that multiple abstracts featuring new data from its dermatology portfolio will be presented at the 2025 American Academy of Dermatology (AAD) Annual Meeting, ...

Tryn Stimart; Chief Legal Officer, CCO, Compliance Officer, Corporate Secretary & Privacy Officer; Abcellera Biologics Inc. Carl L. Hansen; CEO, President & Chairper ...

Right now, Rinvoq is approved in the European Union and the U.S. for the treatment of adults with radiographic axial ...

Results from a Phase III study in pediatric patients demonstrated that Odactra reduced the total combined rhinitis score by 22% compared to placebo.

Despite ongoing progress, structural racism and health disparities continue to shape healthcare practices in ways healthcare providers may not even ...

Derm-Biome Pharmaceuticals Inc. has reported findings from a study of its topical drug DB-007-5 in a well-established ...

The Canine Atopic Dermatitis Treatment Market is projected to grow from USD 1,182.60 million in 2024 to USD 1,620.50 million ...

One poster will share pooled INTEGUMENT data of ZORYVE ® (roflumilast) cream 0.15% in atopic dermatitis (AD) in patients with prior inadequate response, intolerance, and/or contraindications to ...

Enveda gets support from Sanofi to advance AI-driven drug discovery to clinical trials: Boulder, Colorado Friday, February 28, 2025, 16:00 Hrs [IST] Enveda, a leading biotechnolog ...

Lipidor AB (publ) (Nasdaq First North Growth Market: LIPI) publishes its year-end report for the period January - December 2024. The report is available on ...